92 related articles for article (PubMed ID: 27562229)
21. Role of oncogenic KRAS in the prognosis, diagnosis and treatment of colorectal cancer.
Zhu G; Pei L; Xia H; Tang Q; Bi F
Mol Cancer; 2021 Nov; 20(1):143. PubMed ID: 34742312
[TBL] [Abstract][Full Text] [Related]
22. Biomarkers predicting clinical outcome of epidermal growth factor receptor-targeted therapy in metastatic colorectal cancer.
Siena S; Sartore-Bianchi A; Di Nicolantonio F; Balfour J; Bardelli A
J Natl Cancer Inst; 2009 Oct; 101(19):1308-24. PubMed ID: 19738166
[TBL] [Abstract][Full Text] [Related]
23. High sensitivity isoelectric focusing to establish a signaling biomarker for the diagnosis of human colorectal cancer.
Padhan N; Nordling TE; Sundström M; Åkerud P; Birgisson H; Nygren P; Nelander S; Claesson-Welsh L
BMC Cancer; 2016 Aug; 16(1):683. PubMed ID: 27562229
[TBL] [Abstract][Full Text] [Related]
24. Dasatinib sensitizes KRAS mutant colorectal tumors to cetuximab.
Dunn EF; Iida M; Myers RA; Campbell DA; Hintz KA; Armstrong EA; Li C; Wheeler DL
Oncogene; 2011 Feb; 30(5):561-74. PubMed ID: 20956938
[TBL] [Abstract][Full Text] [Related]
25. Resistance to Selumetinib (AZD6244) in colorectal cancer cell lines is mediated by p70S6K and RPS6 activation.
Grasso S; Tristante E; Saceda M; Carbonell P; Mayor-López L; Carballo-Santana M; Carrasco-García E; Rocamora-Reverte L; García-Morales P; Carballo F; Ferragut JA; Martínez-Lacaci I
Neoplasia; 2014 Oct; 16(10):845-60. PubMed ID: 25379021
[TBL] [Abstract][Full Text] [Related]
26. Phosphorylation of p70 Ribosomal Protein S6 Kinase β-1 is an Independent Prognostic Parameter in Metastatic Colorectal Cancer.
Wiesweg M; Reis H; Köster T; Goetz M; Worm K; Herold T; Paul A; Dechêne A; Schumacher B; Markus P; Virchow I; Kostbade K; Wolf N; Zaun G; Metzenmacher M; Schmid KW; Schuler M; Kasper S
Clin Colorectal Cancer; 2018 Jun; 17(2):e331-e352. PubMed ID: 29526493
[TBL] [Abstract][Full Text] [Related]
27. Macrophages stimulate gastric and colorectal cancer invasion through EGFR Y(1086), c-Src, Erk1/2 and Akt phosphorylation and smallGTPase activity.
Cardoso AP; Pinto ML; Pinto AT; Oliveira MI; Pinto MT; Gonçalves R; Relvas JB; Figueiredo C; Seruca R; Mantovani A; Mareel M; Barbosa MA; Oliveira MJ
Oncogene; 2014 Apr; 33(16):2123-33. PubMed ID: 23644655
[TBL] [Abstract][Full Text] [Related]
28. Relationships among
Wan XB; Wang AQ; Cao J; Dong ZC; Li N; Yang S; Sun MM; Li Z; Luo SX
World J Gastroenterol; 2019 Feb; 25(7):808-823. PubMed ID: 30809081
[TBL] [Abstract][Full Text] [Related]
29. The tyrosine phosphatase PTPRO sensitizes colon cancer cells to anti-EGFR therapy through activation of SRC-mediated EGFR signaling.
Asbagh LA; Vazquez I; Vecchione L; Budinska E; De Vriendt V; Baietti MF; Steklov M; Jacobs B; Hoe N; Singh S; Imjeti NS; Zimmermann P; Sablina A; Tejpar S
Oncotarget; 2014 Oct; 5(20):10070-83. PubMed ID: 25301722
[TBL] [Abstract][Full Text] [Related]
30. Capillary nano-immunoassay for Akt 1/2/3 and 4EBP1 phosphorylation in acute myeloid leukemia.
Sabnis H; Bradley HL; Bunting ST; Cooper TM; Bunting KD
J Transl Med; 2014 Jun; 12():166. PubMed ID: 24923301
[TBL] [Abstract][Full Text] [Related]
31. Dragging ras back in the ring.
Stephen AG; Esposito D; Bagni RK; McCormick F
Cancer Cell; 2014 Mar; 25(3):272-81. PubMed ID: 24651010
[TBL] [Abstract][Full Text] [Related]
32. The role of Src in colon cancer and its therapeutic implications.
Chen J; Elfiky A; Han M; Chen C; Saif MW
Clin Colorectal Cancer; 2014 Mar; 13(1):5-13. PubMed ID: 24361441
[TBL] [Abstract][Full Text] [Related]
33. Panitumumab-FOLFOX4 treatment and RAS mutations in colorectal cancer.
Douillard JY; Oliner KS; Siena S; Tabernero J; Burkes R; Barugel M; Humblet Y; Bodoky G; Cunningham D; Jassem J; Rivera F; Kocákova I; Ruff P; Błasińska-Morawiec M; Šmakal M; Canon JL; Rother M; Williams R; Rong A; Wiezorek J; Sidhu R; Patterson SD
N Engl J Med; 2013 Sep; 369(11):1023-34. PubMed ID: 24024839
[TBL] [Abstract][Full Text] [Related]
34. Identification and quantification of AKT isoforms and phosphoforms in breast cancer using a novel nanofluidic immunoassay.
Iacovides DC; Johnson AB; Wang N; Boddapati S; Korkola J; Gray JW
Mol Cell Proteomics; 2013 Nov; 12(11):3210-20. PubMed ID: 23929892
[TBL] [Abstract][Full Text] [Related]
35. Highly multiplexed single-cell analysis of formalin-fixed, paraffin-embedded cancer tissue.
Gerdes MJ; Sevinsky CJ; Sood A; Adak S; Bello MO; Bordwell A; Can A; Corwin A; Dinn S; Filkins RJ; Hollman D; Kamath V; Kaanumalle S; Kenny K; Larsen M; Lazare M; Li Q; Lowes C; McCulloch CC; McDonough E; Montalto MC; Pang Z; Rittscher J; Santamaria-Pang A; Sarachan BD; Seel ML; Seppo A; Shaikh K; Sui Y; Zhang J; Ginty F
Proc Natl Acad Sci U S A; 2013 Jul; 110(29):11982-7. PubMed ID: 23818604
[TBL] [Abstract][Full Text] [Related]
36. PTEN expression profiles in colorectal adenocarcinoma and its precancerous lesions.
Waniczek D; Śnietura M; Młynarczyk-Liszka J; Pigłowski W; Kopeć A; Lange D; Rudzki M; Arendt J
Pol J Pathol; 2013 Apr; 64(1):15-20. PubMed ID: 23625595
[TBL] [Abstract][Full Text] [Related]
37. Cancer incidence and mortality patterns in Europe: estimates for 40 countries in 2012.
Ferlay J; Steliarova-Foucher E; Lortet-Tieulent J; Rosso S; Coebergh JW; Comber H; Forman D; Bray F
Eur J Cancer; 2013 Apr; 49(6):1374-403. PubMed ID: 23485231
[TBL] [Abstract][Full Text] [Related]
38. Nanoproteomic analysis of extracellular receptor kinase-1/2 post-translational activation in microdissected human hyperplastic colon lesions.
Drew DA; Devers T; Horelik N; Yang S; O'Brien M; Wu R; Rosenberg DW
Proteomics; 2013 May; 13(9):1428-36. PubMed ID: 23467982
[TBL] [Abstract][Full Text] [Related]
39.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
40.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Previous] [Next] [New Search]
